Topic

Articles

Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.

Thermo Fisher Scientific Extends Collaboration Support for Biopharma Discovery and Development

GlaxoSmithKline, together with the University of Oxford, has launched the Oxford-GSK Institute under a new collaboration that aims to study complex diseases to accelerate the success of drug discovery and drug development efforts.

GSK and University of Oxford Partner on Disease Research to Advance Drug Discovery and Development

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Can Vaccine Development Be Safely Accelerated?

The strategic alliance provides an integrated product offering around drug discovery and development.

PMI Biopharma Solutions, Nashville Biosciences Partner on Comprehensive Drug Discovery

Experts explore the role gene-editing techniques can play in regenerative medicine and cell-line development.

Gene-Editing Techniques Target New Applications

In this collaboration, AbCellera will apply its expertise to generate panels of antibody candidates for Gilead to evaluate.

Gilead, AbCellera in Therapeutic Antibody Discovery Collaboration

Researchers at the University of Sheffield, Sheffield, UK, have discovered and developed a new compound that can kill antibiotic-resistant bacteria, including Escherichia coli.

New Compound Discovered that Kills Antibiotic-Resistant Microbes

The companies will join forces to use artificial intelligence (AI) and machine learning to discover and develop new treatments for two chronic diseases.

AstraZeneca, BenevolentAI Partner on AI for Drug Discovery

Valitacell and Solentim, have announced a collaboration aimed at the acceleration of discovery and development of biologic drugs and advanced cell therapies.

Valitacell, Solentim Collaborate to Accelerate Development of Breakthrough Medicines

Researchers at the University of Delaware have made a step forward in gene therapy by engineering microparticles that deliver gene-regulating material to hematopoietic stem and progenitor cells, which live deep in bone marrow and direct the formation of blood cells.

Discovery Pipeline